Hurdles to overcome for mesenchymal stem cell translation from bench to bedside

doi:10.4252/wjsc.v17.i12.114349

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (94)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-3)

Sum=81

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=22

Dec 26, 2025 (publication date) through Jan 1, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Dec 26, 2025; 17(12): 114349
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114349

Open in New Tab Full Size Figure Download Figure

Figure 1 Challenges encountered during the translation of mesenchymal stem cell therapy from bench to bedside, and suggested solutions to overcome them. MSC: Mesenchymal stem cell; GMP: Good manufacturing practice.

Citation: Mayeen NF, Salma U, Abu Kasim NH, Mahmoud O, Haque N. Hurdles to overcome for mesenchymal stem cell translation from bench to bedside. World J Stem Cells 2025; 17(12): 114349
URL: https://www.wjgnet.com/1948-0210/full/v17/i12/114349.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.114349